These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 15943961)
1. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961 [TBL] [Abstract][Full Text] [Related]
2. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. Webster LR; Butera PG; Moran LV; Wu N; Burns LH; Friedmann N J Pain; 2006 Dec; 7(12):937-46. PubMed ID: 17157780 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. Hale ME; Dvergsten C; Gimbel J J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415 [TBL] [Abstract][Full Text] [Related]
4. ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety. Katz N; Sun S; Johnson F; Stauffer J J Pain; 2010 Apr; 11(4):303-11. PubMed ID: 19944650 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Nicholson B; Ross E; Sasaki J; Weil A Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075 [TBL] [Abstract][Full Text] [Related]
6. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain. Arora S; Setnik B; Michael D; Hudson JD; Clemmer R; Meisner P; Pixton GC; Goli V; Sommerville KW J Opioid Manag; 2014; 10(6):423-36. PubMed ID: 25531960 [TBL] [Abstract][Full Text] [Related]
8. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815 [TBL] [Abstract][Full Text] [Related]
9. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study. Singla N; Pong A; Newman K; Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605 [TBL] [Abstract][Full Text] [Related]
10. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement. Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613 [TBL] [Abstract][Full Text] [Related]
11. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain. Katz N; Hale M; Morris D; Stauffer J Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975 [TBL] [Abstract][Full Text] [Related]
12. Oxytrex: an oxycodone and ultra-low-dose naltrexone formulation. Webster LR Expert Opin Investig Drugs; 2007 Aug; 16(8):1277-83. PubMed ID: 17685875 [TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438 [TBL] [Abstract][Full Text] [Related]
15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A; Ma C; Ahdieh H; Galer BS Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [TBL] [Abstract][Full Text] [Related]
16. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone. Fishman M Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831 [TBL] [Abstract][Full Text] [Related]
17. Oxycodone combined with opioid receptor antagonists: efficacy and safety. Davis M; Goforth HW; Gamier P Expert Opin Drug Saf; 2013 May; 12(3):389-402. PubMed ID: 23534906 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899 [TBL] [Abstract][Full Text] [Related]
19. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]